| 41/150 | US=23-E / Câncer Roesch A, Landthaler M, Vogt T. Malignant melanoma versus deep penetrating nevus:diagnostic and prognostic immunohistochemistry of dipeptidy1 peptidase IV (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 323-31. ISBN 978-90-481-2917-1. MELANOMA MALIGNO; IMUNO-HISTOQUIMICA; DIPEPTIDE; PEPTIDASE IV; DIPEPTIDIL PEPTIDASE-4; DPP4 |
| 42/150 | US=23-E / Câncer Hafner C. Nonmelanoma skin cancer use of Epha1 receptor as a prognostic marker. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 333-40. ISBN 978-90-481-2917-1. |
| 43/150 | US=23-E / Câncer Fiegl M, Mayer J. Pretreated chronic lymphocytic leukemia: use of alemtuzumab. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 343-58. ISBN 978-90-481-2917-1. LEUCEMIA CRONICA. TRATAMENTO; LINFOCITICA; TRATAMENTO COM USO DE ALEMTUZUMAB |
| 44/150 | US=23-E / Câncer Chatterjee M, Manivannan R, Pande A, Chakraborty T. Immunotherapeutic strategies, radiotherapy, and targeted radionuclide therapy approaches for the treatment of multiple myeloma. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 361-82. ISBN 978-90-481-2917-1. ESTRATEGIAS DE IMUNOTERAPIA; RADIOTERAPIA; TERAPIA; RADIONUCLIDEOS PARA O TRATAMENTO DO MIELOMA MULTIPLO |
| 45/150 | US=23-E / Câncer Matsuyama A, Hisaoka M, Hashimoto H. Low grade fibromyxoid sarcoma: diagnosis by detecting FUS-CREB3L2 fusion gene using reverse transcription-polymerase chain reaction. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 387-92. ISBN 978-90-481-2917-1. SARCOMA DE BAIXO GRAU FIBROMIXOIDE; FUS-CREB3L2; GENE DE FUSAO. REACAO EM CADEIA DE POLIMERASE |
| 46/150 | US=23-E / Câncer Terry J, Nielsen TO. Synovial sarcoma: role of TLE1 as a diagnostic immunohistochemical marker. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 393-403. ISBN 978-90-481-2917-1. SARCOMA SINOVIAL; TLE1 COMO MARCADOR; IMUNO-HISTOQUIMICA. DIAGNOSTICO |
| 47/150 | US=23-E / Câncer Pantanowitz L, Caponetti G, Dezube BJ. The immunohistochemistry of Kaposi's sarcoma. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 405-31. ISBN 978-90-481-2917-1. |
| 48/150 | US=23-E / Câncer Horvai AE. Synovial sarcoma: role of immunohistochemistry and molecular of immunohistochemistry and molecular genetics in diagnosis and prognosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 433-47. ISBN 978-90-481-2917-1. SARCOMA SINOVIAL. DIAGNOSTICO; SARCOMA SINOVIAL. PROGNOSTICO |
| 49/150 | US=23-E / Câncer Fayette J, Cassier P, Brousseau L, Dufresne A, Coquard IR, Alberti L, Méeus P, Decouvelaere AV, Sunyach MP, Ranchère D, Bla JY. Sarcoma: treatment with ecteinascidin-743. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 451-60. ISBN 978-90-481-2917-1. |
| 50/150 | US=24 / Câncer Eric So CW. An overview: from discovery of candidate mutations to disease modeling and transformation mechanisms of acute leukemia. In: Eric So CW, editor. Leukemia: methods and protocols. New York: Humana Press, 2009. p. 1-5. ISBN 978-1-58829-989-5. LEUCEMIA AGUDA; LEUCEMICAS DE CELULAS-TRONCO; FATORES DE TRANSCRICAO; EPIGENETICA; EPIGENOMA; HEMATOPOIESE; AUTO-RENOVACAO; MODELAGEM DE DOENCA |
| 51/150 | US=24 / Câncer Wirmels J, Kang M, Greaves M. Backtracking of leukemic clones to birth. In: Eric So CW, editor. Leukemia: methods and protocols. New York: Humana Press, 2009. p. 7-27. ISBN 978-1-58829-989-5. |
| 52/150 | US=24 / Câncer Konn ZJ, Wright SL, Barber KE, Harrinson CJ. Fluorescence in situ hybridization (FISH) as a tool for the detection of significant chromosomal abnormalities in childhood leukaemia. In: Eric So CW, editor. Leukemia: methods and protocols. New York: Humana Press, 2009. p. 29-55. ISBN 978-1-58829-989-5. SONDAS FISH; CITOGENETICA; MEDULA OSSEA; ANORMALIDADES CROMOSSOMICAS |
| 53/150 | US=24 / Câncer Kearney L, Colman S. Specialized fluorescence in situ hybridization (FISH) techniques for leukaemia research. In: Eric So CW, editor. Leukemia: methods and protocols. New York: Humana Press, 2009. p. 57-70. ISBN 978-1-58829-989-5. |
| 54/150 | US=24 / Câncer Robinson BW, Felix CA. Panhandle PCR approaches to cloning MLL genomic breakpoint junctions and fusion transcript sequences. In: Eric So CW, editor. Leukemia: methods and protocols. New York: Humana Press, 2009. p. 85-114. ISBN 978-1-58829-989-5. MLL; 11Q23; LEUCEMIA; PANHANDLE PCR; INFANTIL; SECUNDARIO; GENE PARCEIRO |
| 55/150 | US=24 / Câncer Meyer C, Marschalek R. LDI-RCR: identification of known and unknown gene fusions of the human MLL gene. In: Eric So CW, editor. Leukemia: methods and protocols. New York: Humana Press, 2009. p. 71-83. ISBN 978-1-58829-989-5. MLL; LDI-PCR; MRD; TRANSLOCACOES CROMOSSOMICAS; REARRANJOS GENETICOS; PARCEIROS GENES DE FUSAO; LEUCEMIA AGUDA; DNA GENOMICO; MARCADOR MOLECULAR |
| 56/150 | US=24 / Câncer van der Velden VHJ, van Dongen JJM. MRD detection in acute lymphoblastic leukemia patients using Ig/TCR gene rearrangements as targets for real-time quantitative PCR. In: Eric So CW, editor. Leukemia: methods and protocols. New York: Humana Press, 2009. p. 115-50. ISBN 978-1-58829-989-5. MLL; 11Q23; LEUCEMIA; PANHANDLE PCR; INFANTIL; SECUNDARIO; GENE PARCEIRO |
| 57/150 | US=24 / Câncer Strefford JC, Parker H. Array-based comparative genomic hybridization as a tool for analyzing the leukemia genome. In: Eric So CW, editor. Leukemia: methods and protocols. New York: Humana Press, 2009. p. 151-77. ISBN 978-1-58829-989-5. HIBRIDIZACAO GENOMICA COMPARATIVA; CGH; MICROARRAY; COPIAR MUDANCAS DE NUMEROS; LEUCEMIA LINFOBLASTICA AGUDA |
| 58/150 | US=24 / Câncer Gupta M, Young BD. Application of SNP genotype arrais to determine somatic changes in cancer. In: Eric So CW, editor. Leukemia: methods and protocols. New York: Humana Press, 2009. p. 179-206. ISBN 978-1-58829-989-5. MICROARRAYS SNP; MUDANCA DO NUMERO DE COPIA DO DNA; PERDA DE HETEROZIGOSE; DISSOMIA UNIPARENTAL; HOMOZIGOTIA ADQUIRIDO |
| 59/150 | US=24 / Câncer Zeisig Bernd B, Eric So CW. Retroviral/lentiviral transduction and transformation assay. In: Eric So CW, editor. Leukemia: methods and protocols. New York: Humana Press, 2009. p. 207-29. ISBN 978-1-58829-989-5. LEUCEMIA AGUDA; AML; ONCOGENE; GENE DE FUSAO; ENSAIO REPIQUE DE SERIE; TRANSFORMACAO DE CELULAS PRIMARIAS; AUTO-RETROVIRAIS; LENTIVIRUS |
| 60/150 | US=24 / Câncer Krivtsov AV, Wang Y, Feng Z, Armstrong SA. Gene expression profiling of leukemia stem cells. In: Eric So CW, editor. Leukemia: methods and protocols. New York: Humana Press, 2009. p. 231-46. ISBN 978-1-58829-989-5. EXPRESSAO GENICA DE CELULAS-TRONCO DA LEUCEMIA; CELULAS ESTAMINAIS; TRONCO CELULAS DE LEUCEMIA; PERFIL DE EXPRESSAO GENICA; MICROARRAY; MLL-AF9; LEUCEMIA; EXPRESSAO DO GENE; AMPLIFICACAO DO RNA |